1956 related articles for article (PubMed ID: 7817375)
1. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
[TBL] [Abstract][Full Text] [Related]
3. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
[TBL] [Abstract][Full Text] [Related]
4. The Dai minority population of southwest China: heterogeneity of DR2-associated HLA-DRB1,DRB5,DQA1, and DQB1 haplotypes.
Fan L; Chandanayingyong D; Smith AG; Hansen JA
Hum Immunol; 1996 Feb; 45(2):143-7. PubMed ID: 8882413
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism and distribution of HLA-DR2 alleles and haplotypes in a Greek population.
Constantinidou N; Chaidaroglou A; Van den Berg-Loonen EM; Koniavitou K
Tissue Antigens; 1998 Aug; 52(2):153-7. PubMed ID: 9756404
[TBL] [Abstract][Full Text] [Related]
6. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HLA haplotypes in families with type 1 diabetes mellitus in La Réunion island.
Feugeas JP; Tortosa P; Dulay S; Augustin-Pascalis I; Charron D; Krishnamoorthy R; Caillens H; Montchamp-Moreau C
Eur J Immunogenet; 1996 Dec; 23(6):459-70. PubMed ID: 8971543
[TBL] [Abstract][Full Text] [Related]
8. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients.
Zeliszewski D; Tiercy JM; Boitard C; Gu XF; Loche M; Krishnamoorthy R; Simonney N; Elion J; Bach JF; Mach B
Hum Immunol; 1992 Feb; 33(2):140-7. PubMed ID: 1348743
[TBL] [Abstract][Full Text] [Related]
9. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
[TBL] [Abstract][Full Text] [Related]
10. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles.
Hu CY; Allen M; Chuang LM; Lin BJ; Gyllensten U
Hum Immunol; 1993 Oct; 38(2):105-14. PubMed ID: 8106265
[TBL] [Abstract][Full Text] [Related]
11. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus.
Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A
Tissue Antigens; 1995 Feb; 45(2):148-52. PubMed ID: 7792764
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians.
Djoulah S; Khalil I; Beressi JP; Benhamamouch S; Bessaoud K; Deschamps I; Degos L; Hors J
Eur J Immunogenet; 1992 Dec; 19(6):381-9. PubMed ID: 1477090
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey.
Saruhan-Direskeneli G; Uyar FA; Bas F; Günöz H; Bundak R; Saka N; Darendeliler F
Hum Immunol; 2000 Mar; 61(3):296-302. PubMed ID: 10689119
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population.
Mehra NK; Verduijn W; Taneja V; Drabbels J; Singh SP; Giphart MJ
Hum Immunol; 1991 Dec; 32(4):246-53. PubMed ID: 1783571
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population.
Balducci-Silano PL; Layrisse Z; Dominguez E; Amaro R; Gunczler P; Lanes R; Zaro R
Eur J Immunogenet; 1994 Dec; 21(6):405-14. PubMed ID: 9098450
[TBL] [Abstract][Full Text] [Related]
17. Distribution of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe.
Garcia-Pacheco JM; Herbut B; Cutbush S; Hitman GA; Zhonglin W; Magzoub M; Bottazzo GF; Kiere C; West G; Mvere D
Tissue Antigens; 1992 Sep; 40(3):145-9. PubMed ID: 1440568
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania.
Gao XJ; Serjeantson SW
Immunogenetics; 1991; 34(6):401-8. PubMed ID: 1748488
[TBL] [Abstract][Full Text] [Related]
19. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
20. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
